
27th January 2025
Johnson Matthey Plc
(the Company)
Establishment of Investment Committee
The Company is pleased to announce the establishment of an Investment Committee (the "Committee") of the Board. The Committee, established on 24th January 2025, will reinforce the Company's investment strategies and capital allocation.
The Board recognises the need for the Company to remain agile in uncertain markets and adapt its investment strategy and capital allocation as needed, alongside identifying initiatives to accelerate and deliver cash generation and enhanced returns on capital. The Committee will provide additional oversight to these areas in line with the Company's commitment to delivering sustainable shareholder value.
Specific responsibilities of the Committee will include review and endorsement of i) investment and capital allocation strategy, ii) major capital projects and, iii) M&A activity. In discharging these duties, the Committee will give consideration to leading market indicators, execution risk, and levels of return and cash generation for shareholders.
The Committee will be chaired by Barbara Jeremiah, Senior Independent Director and will initially consist of the following additional members:
Liam Condon Chief Executive
Sinead Lynch Independent Non-Executive Director
Stephen Oxley Chief Financial Officer
Doug Webb Independent Non-Executive Director
The Committee's Terms of Reference will shortly be available on our website: www.matthey.com/governance-framework
This announcement is made in compliance with the Company's obligations under the UK Listing Rules ("UKLR"), specifically UKLR 6.4.6R.
ENDS
|
Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)
Registered in England & Wales number: 00033774
Legal Entity Identifier number: 2138001AVBSD1HSC6Z10
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.